We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Willdan Group
WLDN
$1.3B
| $458K | ﹤0.01% |
12,160
-1,312
| -10% | -$50.7K |
|
|
XXII
2602
22nd Century Group
XXII
$1.48M
| – | – |
0
| – | – |
|
2603
Butterfly Network
BFLY
$2.35B
| $456K | ﹤0.01% |
+31,494
| New | +$425K |
|
2604
Clearfield
CLFD
$374M
| $456K | ﹤0.01% |
12,168
-1,208
| -9% | -$42.9K |
|
|
CBAY
2605
DELISTED
Cymabay Therapeutics
CBAY
| $454K | ﹤0.01% |
104,101
-12,360
| -11% | -$54.8K |
|
|
SIEN
2606
DELISTED
Sientra, Inc.
SIEN
| $453K | ﹤0.01% |
5,690
+105
| +2% | +$7.46K |
|
2607
Intrepid Potash
IPI
$469M
| $451K | ﹤0.01% |
14,169
-1,529
| -10% | -$45.1K |
|
2608
VistaGen Therapeutics
VTGN
$12.8M
| $449K | ﹤0.01% |
+4,755
| New | +$352K |
|
2609
Babcock & Wilcox
BW
$1.39B
| $446K | ﹤0.01% |
+56,602
| New | +$467K |
|
|
ADVM
2610
DELISTED
Adverum Biotechnologies
ADVM
| $445K | ﹤0.01% |
12,705
+1,760
| +16% | +$94.8K |
|
2611
Accuray
ARAY
$34M
| $445K | ﹤0.01% |
98,472
-7,141
| -7% | -$33.4K |
|
2612
BioAtla
BCAB
$5.74M
| $445K | ﹤0.01% |
210
-6
| -3% | -$13.6K |
|
|
NAGE
2613
Niagen Bioscience
NAGE
$247M
| $445K | ﹤0.01% |
45,105
-1,191
| -3% | -$10.4K |
|
|
TECX
2614
Tectonic Therapeutic
TECX
$585M
| $444K | ﹤0.01% |
4,161
+1,075
| +35% | +$127K |
|
|
CNBKA
2615
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $443K | ﹤0.01% |
3,884
-489
| -11% | -$55.2K |
|
|
AMNB
2616
DELISTED
American National Bankshares Inc
AMNB
| $443K | ﹤0.01% |
14,250
-2,299
| -14% | -$77.4K |
|
2617
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
| $441K | ﹤0.01% |
4,193
-234
| -5% | -$24.7K |
|
2618
Artesian Resources
ARTNA
$358M
| $440K | ﹤0.01% |
11,975
-1,556
| -11% | -$62.1K |
|
2619
Cartesian Therapeutics
RNAC
$268M
| $440K | ﹤0.01% |
3,507
+1,196
| +52% | +$142K |
|
|
XONE
2620
DELISTED
The ExOne Company
XONE
| $440K | ﹤0.01% |
20,320
+8,148
| +67% | +$185K |
|
2621
Kopin
KOPN
$791M
| $439K | ﹤0.01% |
+53,657
| New | +$444K |
|
|
DSSI
2622
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $439K | ﹤0.01% |
44,085
-2,388
| -5% | -$24.8K |
|
2623
First Internet Bancorp
INBK
$255M
| $437K | ﹤0.01% |
14,108
-1,649
| -10% | -$56K |
|
2624
Lifecore Biomedical
LFCR
$190M
| $437K | ﹤0.01% |
38,833
-7,056
| -15% | -$81.3K |
|
|
TACO
2625
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $437K | ﹤0.01% |
43,653
-5,450
| -11% | -$57.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.